Pax Financial Group, LLC Novo Nordisk A S Transaction History

Pax Financial Group, LLC

  • $531 Million
  • Q3 2024

A detailed history of Pax Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pax Financial Group, LLC holds 5,206 shares of NVO stock, worth $551,627. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,206
Previous 6,401 18.67%
Holding current value
$551,627
Previous $913,000 32.2%
% of portfolio
0.12%
Previous 0.19%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $142,288 - $173,776
-1,195 Reduced 18.67%
5,206 $619,000
Q2 2024

Aug 14, 2024
SELL
$122.71 - $146.91 $29,573 - $35,405
-241 Reduced 3.63%
6,401 $913,000
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $57,794 - $76,930
-566 Reduced 7.85%
6,642 $852,000
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $20,364 - $24,464
-232 Reduced 3.12%
7,208 $745,000
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $320,654 - $703,578
3,526 Added 90.09%
7,440 $676,000
Q2 2023

Jul 18, 2023
SELL
$155.98 - $172.65 $12,790 - $14,157
-82 Reduced 2.05%
3,914 $633,000
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $98,328 - $118,241
-743 Reduced 15.68%
3,996 $635,000
Q4 2022

Feb 10, 2023
SELL
$102.55 - $135.33 $163,259 - $215,445
-1,592 Reduced 25.15%
4,739 $641,000
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $11,147 - $13,680
-117 Reduced 1.81%
6,331 $631,000
Q2 2022

Aug 09, 2022
SELL
$103.24 - $121.81 $302,183 - $356,537
-2,927 Reduced 31.22%
6,448 $719,000
Q1 2022

May 10, 2022
SELL
$93.1 - $112.54 $49,063 - $59,308
-527 Reduced 5.32%
9,375 $1.04 Million
Q4 2021

Feb 07, 2022
SELL
$95.88 - $117.08 $56,377 - $68,843
-588 Reduced 5.61%
9,902 $1.11 Million
Q3 2021

Oct 29, 2021
SELL
$84.42 - $106.62 $36,131 - $45,633
-428 Reduced 3.92%
10,490 $1.01 Million
Q2 2021

Aug 13, 2021
BUY
$67.66 - $84.76 $43,776 - $54,839
647 Added 6.3%
10,918 $915,000
Q1 2021

May 10, 2021
BUY
$67.06 - $75.82 $122,049 - $137,992
1,820 Added 21.54%
10,271 $692,000
Q4 2020

Feb 03, 2021
BUY
$63.89 - $73.8 $23,064 - $26,641
361 Added 4.46%
8,451 $590,000
Q3 2020

Nov 12, 2020
BUY
$63.69 - $70.22 $61,970 - $68,324
973 Added 13.67%
8,090 $562,000
Q2 2020

Jul 31, 2020
BUY
$58.54 - $67.94 $45,953 - $53,332
785 Added 12.4%
7,117 $466,000
Q1 2020

Apr 28, 2020
BUY
$49.46 - $64.78 $72,013 - $94,319
1,456 Added 29.86%
6,332 $411,000
Q4 2019

Feb 21, 2020
BUY
$49.86 - $58.26 $243,117 - $284,075
4,876 New
4,876 $313,000

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pax Financial Group, LLC Portfolio

Follow Pax Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pax Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pax Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email